Citations

Showing 10 of 108081 citations.

Readability Assessment of Online Obstetrics and Gynecology Patient-Oriented Literature [2O]
Trinidad, Mari Charisse, Richards, Elliott G.

Mayo Clinic

Obstetrics & Gynecology | May 6, 2017 | Volume: 129 | Issue: 1 | Pages: S153-S153

10.1097/01.aog.0000514751.23683.67 Get It

INTRODUCTION: As the Internet has become the primary source of health information for most patients, there is limited information regarding the readability of available online information for patients in obstetrics and gynecology. METHODS: Twenty-four phrases from “Top Searches on ACOG” were used as search terms, using search engine optimization tools, mirroring likely patient search patterns. Contents were then analyzed for readability using four validated readability formulas, including Flesch Reading Ease Score (FRES), Flesch-Kincaid Grade Level (FKGL), Simple Measure of Gobbledygook (SMOG), and Gunning Fog Index (GFOG). RESULTS: A total of 214 webpages were evaluated and majority had readability scores higher than currently recommended for patient-directed information. The mean FRES was 56.0 (range, 26.6 to 97.0), with majority (99%) of the sites scoring less than 80, correlating with a “difficult” level of reading. Mean readability grade levels were as follows: 6.86 for FKGL; 8.39 for SMOG; and 8.28 for GFOG. Of the 24 topic areas, only 11 (45.8%) had easily accessible patient related documents published by the American College of Obstetricians and Gynecologists. CONCLUSION: To our knowledge, this is the first study providing a broad assessment of readability of currently available online patient related information in obstetrics and gynecology. Consistent with other specialties, the readability of most online obstetrics and gynecology patient materials is unsatisfactory. While readability level is only one component of useful patient-oriented literature, there is a great need for effective and easily accessible online patient-oriented websites as health literacy can impact outcomes.
Rate of Spontaneous Version Following Preterm Premature Rupture of Membranes [28N]
Banerjee, Dipti, Codsi, Elisabeth , Borowski, Kristi

Mayo Clinic

Obstetrics & Gynecology | May 6, 2017 | Volume: 129 | Issue: 1 | Pages: 150S-150S

10.1097/01.aog.0000514738.77941.e0 Get It

INTRODUCTION: Malpresentation is a common problem early in pregnancy. The rate of spontaneous version (SV) by gestational age has been studied, but is poorly understood after preterm premature rupture of membranes (PPROM), which complicates 3% of pregnancies in the United States. The objective of our study was to report the rate of SV following PPROM. METHODS: We conducted a retrospective cohort study on women age 18 or above with singleton intrauterine pregnancies who experienced PPROM between 22-34 weeks gestation and were delivered at the Mayo Clinic from 01/2010-12/2015. Demographic characteristics, obstetric history, and prenatal care details were abstracted through chart review. Aneuploidy, major fetal anomalies, maternal Müllerian anomalies, and delivery less than 24 hours after PPROM were excluded. RESULTS: Among 120 patients included in the study, 29 were nulliparous. Mean maternal age at PPROM diagnosis was 29.3 years. The median gestational age at PPROM diagnosis and at delivery was 31 1/7 weeks and 32 5/7 weeks, respectively. Intrauterine growth restriction was diagnosed in 10 women following PPROM. Sixty-nine (57.5%) patients delivered vaginally and 51 (42.5%) underwent cesarean section. Twenty-three (19.2%) women experienced SV following PPROM. Of the 21 breech presentations at PPROM diagnosis, 4 (19%) converted to cephalic presentation at delivery. CONCLUSION: We determined that approximately 1 out of 5 women experience SV in the setting of PPROM. Data about SV following PPROM is important in order to counsel patients about expectations for the remainder of their pregnancy. This new evidence can better prepare patients and providers for safe delivery.
Frequency of Peripartum Gestational Hypertension and Associated Adverse Outcomes [8L]
Codsi, Elisabeth , Borowski, Krist S., White, Wendy W., Garovic, Vesna D. , Borowski, Kristi

Mayo Clinic

Obstetrics & Gynecology | May 6, 2017 | Volume: 129 | Issue: 1 | Pages: 123S-124S

10.1097/01.aog.0000514639.61526.25 Get It

INTRODUCTION: Criteria for gestational hypertension (GH) include only 2 systolic blood pressures (BP) equal or greater than 140 or diastolic BP equal or greater than 90 at least 4 hours apart after 20 weeks gestation. We sought to determine the frequency of previously-normotensive patients meeting criteria for GH when presenting for delivery, and its association with adverse maternal/fetal outcomes. METHODS: We performed a retrospective cohort study of consecutive term deliveries without a diagnosis of hypertensive disorder of pregnancy (HDP) prior to admission. Characteristics of BP elevations, evaluations for and diagnosis of HDP; and associations with adverse composite maternal (seizure, pulmonary edema, unplanned ICU admission, emergent treatment of HTN, stroke, death) or fetal adverse events (5 minute Apgar more than 7, death or unplanned NICU admission) were determined. RESULTS: Of 185 patients, 140 (76%) had at least 1 BP elevation and 55 (30%) met formal criteria for HDP. Most elevated BPs occurred from admission to 1 hour postpartum (73%). Of those meeting GH criteria, only 18 (10%) underwent evaluation and 16 (9%) were formally diagnosed with HDP. A higher rate of fetal composite outcomes (7% vs 1%) was found in patients meeting criteria for HDP. CONCLUSION: BP elevations during admission for delivery were common, and though 30% met the strict definition for GH, only 9% were formally diagnosed reflecting low clinical suspicion. BP elevations through 1 hour postpartum appear to be most often a normal physiologic response to stress rather than a manifestation of HDP, yet GH is associated with risk for poor fetal outcomes.
Risk Factors for Postpartum Hemorrhage Following Nulliparous Induction of Labor [3C]
Holman, Michelle A., McGree, Michaela E. , Weaver, Amy, Torbenson, Vanessa E. , Tolcher, Mary Catherine , Ainsworth, Alessandra J.

Mayo Clinic

Obstetrics & Gynecology | May 6, 2017 | Volume: 129 | Issue: 1 | Pages: 31S-31S

10.1097/01.aog.0000514312.69761.62 Get It

INTRODUCTION: Postpartum hemorrhage is the leading cause of maternal mortality worldwide. There are multiple known risk factors, including induction of labor. METHODS: A retrospective cohort study was completed with review of nulliparous women undergoing labor induction at term, from July 2006 to May 2011. Baseline maternal variables and risk factors for postpartum hemorrhage were assessed. All combinations of methods of induction were sequential rather than concurrent. The need for additional uterotonics (beyond routine oxytocin) was used as a surrogate for postpartum hemorrhage. Variables were evaluated for an association with additional uterotonic use based on fitting logistic regression models. RESULTS: A total of 785 women were included in the study. Additional uterotonics were required for 84/785 (11%) of women. Based on univariate analysis, only birth weight and presence of meconium were significantly (p < 0.05) associated with additional uterotonic use, while method of induction approached statistical significance (p=0.06). The mean (SD) birth weight was 3668 (584) vs. 3463 (500) grams in those with and without additional uterotonic use. Multivariate analysis showed an increased risk of additional uterotonics with higher birth weight (adjusted odds ratio (aOR) 1.44 per 500 gram increase in birth weight; 95% CI 1.15, 1.82) and use of Foley plus oxytocin (aOR 4.40; 95% CI 1.36, 14.23). CONCLUSION: In our model, higher birth weight and induction method of Foley followed by oxytocin were associated with increased need for additional uterotonics. This data adds detail to previous studies that have broadly identified induction of labor as a risk factor for postpartum hemorrhage.
Decisional Regret in Women Receiving High-Risk Results From Non-Invasive Prenatal Genetic Screening [24B]
Allyse, Megan

Mayo Clinic

Obstetrics & Gynecology | May 6, 2017 | Volume: 129 | Issue: 1 | Pages: 26S-26S

10.1097/01.aog.0000514294.73333.b4 Get It

INTRODUCTION: Non-invasive prenatal testing (NIPT) panels have expanded rapidly from limited aneuploidy screening for trisomy 21 to expanded screening for aneuploidies and abnormalities, including sex chromosome aneuploidies and, recently, microdeletions. This study sought to understand the experiences of women receiving NIPT results and the effect of high-risk, false, or inconclusive results on maternal anxiety and pursuit of additional testing. METHODS: 40 semi-structured telephone interviews were conducted with women who were currently or had recently been pregnant and received high risk (n=15), false positive/negative (n=19), or inconclusive (n=5) results from NIPT. RESULTS: Many women felt deceived by the advertised “99% accuracy” statistic of NIPT and asserted that much of their post-test anxiety could have been prevented by improved pre-test counseling. Several women felt pressured by providers to terminate, and most felt pressured to pursue invasive diagnostic testing. False results from NIPT had significant lasting effects the remainder of their pregnancies, their willingness to have more children, and their openness to doing NIPT again. Most women would not do NIPT in future pregnancies or would only do it if the panel was smaller. CONCLUSION: Findings suggest significant concerns about how clinical practices are integrating NIPT. Study participants indicate problems with the dialogue when NIPT is offered, the return of results, and the positive predictive value of expanded screenings. Given the confusion about NIPT accuracy, the prevalence of follow-up invasive tests, and the large number of women who regret doing NIPT, NIPT offering and the delivery of results need to be carefully approached.
Reproductive Uterine Transplantation: Ethical Considerations [30P]
Allyse, Megan , Allyse, Megan A

Mayo Clinic

Obstetrics & Gynecology | May 6, 2017 | Volume: 129 | Issue: 1 | Pages: S171-S171

10.1097/01.aog.0000514103.41407.f9 Get It

INTRODUCTION: The recent live births of five babies after elective uterine transplantation from a live donor has demonstrated one possible mechanism to address absolute uterine factor infertility. However, national and cultural factors contributed to the ethical and medical permissibility of uterine transplant in the Swedish context. These factors may be different in other socio-national contexts. We sought to understand the potential permissibility of the procedure in the US context. METHODS: We conducted an ethical analysis of the potential practice of elective reproductive uterine transplantation in the US from a perspective of women's health and rights. RESULTS: Relevant vectors of analysis include alternative paths to parenthood, considerations of baseline status versus enhancement, reproductive rights, feminist critiques, allocation of healthcare resources, and the balance of risk and benefit. Compelling arguments are made on both sides of the deliberation under all vectors. CONCLUSION: On balance, arguments for or against elective uterine transplant in the US context appeared to balance. However, the most compelling factors that must be addressed in order to justify the procedure include the absence of alternatives, the risk to donors and recipients, and the healthcare opportunity costs.
Impact of Telemedicine Monitoring of Community ICUs on Interhospital Transfers*
Pannu, Jasleen , Sanghavi, Devang , Sheley, Todd, Schroeder, Darrell R. , Marquez, Alberto , Brown, Daniel R. , Caples, Sean M., Kashyap, Rahul , Daniels, Craig , Schroeder, Darrell

Mayo Clinic

Critical Care Medicine | May 6, 2017 | Volume: 45 | Issue: 8 | Pages: 1344-1351

10.1097/ccm.0000000000002487 | PMID 28481753 Get It

Objectives: To study the effects of tele-ICU monitoring on interhospital transfers from community-based ICUs to the quaternary care hospital at Mayo Clinic, Rochester, MN. Design: This is a retrospective review of data on interhospital transfers comparing trends prior to tele-ICU implementation to those following implementation. Setting: Tele-ICU programs are increasingly utilized to fill resource gaps in caring for critically ill patients. How such programs impact population and bed management within a healthcare system are not known. Mayo Clinic serves as quaternary referral care center for hospitals in the region within the Mayo Clinic Health System. In August 2013, we implemented tele-ICU monitoring at six Mayo Clinic Health System hospital ICUs. Subjects: All adult ICU admissions during the study period (preimplementation phase: January 1, 2012, to December 31, 2012; and postimplementation phase: January 1, 2014, to December 31, 2014) in any of the six specified community ICUs were included in the study. Measurements and Main Results: Interhospital transfers significantly increased post institution of tele-ICU (p = 0.040) and was attributed primarily to transfer from less specialized ICUs (p = 0.037) as compared with more resource-intensive ICUs (p = 0.88). However, for such patient transfers, there were no significant differences before and after severity of illness scores, ICU mortality, or inhospital mortality. Conclusion: In a regional healthcare system, implementation of a tele-ICU program is associated with an increase in interhospital transfers from less resourced ICUs to the referral center, a trend that is not readily explained by increased severity of illness.
Real-Time Methylation-Specific Polymerase Chain Reaction for MGMT Promoter Methylation Clinical Testing in Glioblastoma
Butz, Malinda L., Jenkins, Robert B. , Kitange, Gaspar J. , Kipp, Benjamin R. , Ida, Cristiane M. , Sarkaria, Jann N. , Giannini, Caterina

Mayo Clinic

American Journal of Clinical Pathology | May 6, 2017 | Volume: 148 | Issue: 4 | Pages: 296-307

10.1093/ajcp/aqx073 | PMID 28967952 Get It

Abstract Objectives To develop and evaluate a real-time methylation-specific polymerase chain reaction (RT-MSP) MGMT assay, with a particular focus on small biopsies and indeterminate testing results. Methods We assessed formalin-fixed paraffin-embedded glioblastoma or gliosarcoma specimens (n = 641). A test-validation group (n = 51) with previously obtained reference laboratory (RL) results was used to determine performance characteristics of the RT-MSP assay. An indeterminate (equivocal) category was established for cases that could not be clearly classified as positive or negative. Results Overall agreement of RT-MSP and RL results was 91% (41/45 nonindeterminate cases). Discordant cases were tested by pyrosequencing, and results were most concordant with RT-MSP. Among cases with limited amounts of tissue (n = 7), six yielded valid results by RT-MSP (all negative); the single invalid result consisted of a stereotactic biopsy specimen obtained 14 years prior. A subset of indeterminate cases obtained during clinical testing (n = 18/575 [3%]) was also evaluated by pyrosequencing and showed a heterogeneous pattern of methylation across the eight interrogated CpG sites. Conclusions The RT-MSP assay that we developed in-house is a robust clinical detection method for the heterogeneous process of MGMT promoter methylation in glioblastoma.
Estimating patient dose from CT exams that use automatic exposure control: Development and validation of methods to accurately estimate tube current values
McMillan, Kyle, Bostani, Maryam, Cagnon, Christopher H., Yu, Lifeng , Cagnon, Chris H., Yu, Lifeng , Leng, Shuai , McCollough, Cynthia H. , McNitt‐Gray, Michael F.

Mayo Clinic

Medical Physics | May 6, 2017 | Volume: 44 | Issue: 8 | Pages: 4262-4275

10.1002/mp.12314 | PMID 28477342 Get It

PurposeThe vast majority of body CT exams are performed with automatic exposure control (AEC), which adapts the mean tube current to the patient size and modulates the tube current either angularly, longitudinally or both. However, most radiation dose estimation tools are based on fixed tube current scans. Accurate estimates of patient dose from AEC scans require knowledge of the tube current values, which is usually unavailable. The purpose of this work was to develop and validate methods to accurately estimate the tube current values prescribed by one manufacturer's AEC system to enable accurate estimates of patient dose.MethodsMethods were developed that took into account available patient attenuation information, user selected image quality reference parameters and x‐ray system limits to estimate tube current values for patient scans. Methods consistent with AAPM Report 220 were developed that used patient attenuation data that were: (a) supplied by the manufacturer in the CT localizer radiograph and (b) based on a simulated CT localizer radiograph derived from image data. For comparison, actual tube current values were extracted from the projection data of each patient. Validation of each approach was based on data collected from 40 pediatric and adult patients who received clinically indicated chest (n = 20) and abdomen/pelvis (n = 20) scans on a 64 slice multidetector row CT (Sensation 64, Siemens Healthcare, Forchheim, Germany). For each patient dataset, the following were collected with Institutional Review Board (IRB) approval: (a) projection data containing actual tube current values at each projection view, (b) CT localizer radiograph (topogram) and (c) reconstructed image data. Tube current values were estimated based on the actual topogram (actual‐topo) as well as the simulated topogram based on image data (sim‐topo). Each of these was compared to the actual tube current values from the patient scan. In addition, to assess the accuracy of each method in estimating patient organ doses, Monte Carlo simulations were performed by creating voxelized models of each patient, identifying key organs and incorporating tube current values into the simulations to estimate dose to the lungs and breasts (females only) for chest scans and the liver, kidney, and spleen for abdomen/pelvis scans. Organ doses from simulations using the actual tube current values were compared to those using each of the estimated tube current values (actual‐topo and sim‐topo).ResultsWhen compared to the actual tube current values, the average error for tube current values estimated from the actual topogram (actual‐topo) and simulated topogram (sim‐topo) was 3.9% and 5.8% respectively. For Monte Carlo simulations of chest CT exams using the actual tube current values and estimated tube current values (based on the actual‐topo and sim‐topo methods), the average differences for lung and breast doses ranged from 3.4% to 6.6%. For abdomen/pelvis exams, the average differences for liver, kidney, and spleen doses ranged from 4.2% to 5.3%.ConclusionsStrong agreement between organ doses estimated using actual and estimated tube current values provides validation of both methods for estimating tube current values based on data provided in the topogram or simulated from image data.
INDIE-HFpEF (Inorganic Nitrite Delivery to Improve Exercise Capacity in Heart Failure With Preserved Ejection Fraction)
Reddy, Yogesh N.V. , Shah, Sanjiv J. , LeWinter, Martin M. , Semigran, Marc J., Dávila‐Román, Víctor G. , Anstrom, Kevin J. , Redfield, Margaret M. , Borlaug, Barry A. , LeWinter, Martin, Semigran, Marc, Davila-Roman, Victor G, Anstrom, Kevin, Hernandez, Adrian, Lewis, Gregory D. , Shah, Sanjiv J , Hernandez, Adrian F. , Braunwald, Eugene , Nishimura, Rick , Borlaug, Barry A

Mayo Clinic

Circulation: Heart Failure | May 6, 2017 | Volume: 10 | Issue: 5 | Pages: No page available

10.1161/circheartfailure.117.003862 | PMID 28476756 Get It

Approximately half of patients with heart failure have preserved ejection fraction. There is no proven treatment that improves outcome. The pathophysiology of heart failure with preserved ejection fraction is complex and includes left ventricular systolic and diastolic dysfunction, pulmonary vascular disease, endothelial dysfunction, and peripheral abnormalities. Multiple lines of evidence point to impaired nitric oxide (NO)-cGMP bioavailability as playing a central role in each of these abnormalities. In contrast to traditional organic nitrate therapies, an alternative strategy to restore NO-cGMP signaling is via inorganic nitrite. Inorganic nitrite, previously considered to be an inert byproduct of NO metabolism, functions as an important in vivo reservoir for NO generation, particularly under hypoxic and acidosis conditions. As such, inorganic nitrite becomes most active at times of greater need for NO signaling, as during exercise when left ventricular filling pressures and pulmonary artery pressures increase. Herein, we present the rationale and design for the INDIE-HFpEF trial (Inorganic Nitrite Delivery to Improve Exercise Capacity in Heart Failure with Preserved Ejection Fraction), which is a multicenter, randomized, double-blind, placebo-controlled cross-over study assessing the effect of inhaled inorganic nitrite on peak exercise capacity, conducted in the National Heart, Lung, and Blood Institute–sponsored Heart Failure Clinical Research Network. Clinical Trial Registration URL: http://www.clinicaltrials.gov . Unique identifier: NCT02742129.